| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2022 | — | Scotiabank | Downgrades | Sector Perform → Sector Underperform | |
| 01/26/2022 | 61.82% | HSBC | → $22 | Upgrades | Hold → Buy |
| 12/14/2021 | 47.11% | Santander | → $20 | Downgrades | Buy → Hold |
| 09/21/2021 | 135.38% | B of A Securities | → $32 | Reinstates | → Buy |
| 04/22/2021 | 47.11% | HSBC | → $20 | Downgrades | Buy → Hold |
| 01/24/2020 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 12/20/2019 | 10.33% | JP Morgan | $17 → $15 | Maintains | Neutral |
Braskem Questions & Answers
The latest price target for Braskem (NYSE: BAK) was reported by Scotiabank on August 15, 2022. The analyst firm set a price target for $0.00 expecting BAK to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Braskem (NYSE: BAK) was provided by Scotiabank, and Braskem downgraded their sector underperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Braskem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Braskem was filed on August 15, 2022 so you should expect the next rating to be made available sometime around August 15, 2023.
While ratings are subjective and will change, the latest Braskem (BAK) rating was a downgraded with a price target of $0.00 to $0.00. The current price Braskem (BAK) is trading at is $13.60, which is out of the analyst's predicted range.